MarketsFN

Microchip Technology (MCHP) Q3 2026 Financial Results Summary

· Stocks · QuoteReporter

Microchip Technology (MCHP) Q3 2026 Financial Results Summary

Chandler, Arizona – On February 5, 2026, Microchip Technology Incorporated reported its financial results for the third quarter of fiscal year 2026, covering the three months ended December 31, 2025. The report highlighted significant growth across various financial metrics compared to the same quarter a year ago.

Key Financial Highlights

Guidance and Future Outlook

Summary of Non-GAAP Financial Metrics

Insights from Leadership

Conclusion

Microchip Technology demonstrated strong financial performance in Q3 of fiscal 2026, marked by significant growth in sales, profitability, and operational improvements. The declared dividend reflects the company’s commitment to return value to its shareholders, further underscoring its good trajectory in generating cash flow and managing debt effectively. The positive guidance sets an optimistic tone for the company as it moves into the next quarter.

For further insights and detailed results, stakeholders can refer to the full financial statements on Microchip Technology’s investor relations page or tune in to the upcoming conference call discussions.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share amounts; unaudited)

Three Months Ended December 31, 2025 2024 Nine Months Ended December 31, 2025 2024
Net sales $1,186.0 $1,026.0 $3,401.9 $3,431.1
Cost of sales $479.1 $464.6 $1,480.4 $1,464.3
Gross profit $706.9 $561.4 $1,921.5 $1,966.8
Research and development $274.3 $246.2 $792.1 $728.6
Selling, general and administrative $168.5 $158.2 $500.1 $465.7
Amortization of acquired intangible assets $107.6 $122.6 $323.3 $368.3
Special charges and other, net $4.8 $3.5 $33.3 $7.6
Operating expenses $555.2 $530.5 $1,648.8 $1,570.2
Operating income $151.7 $30.9 $272.7 $396.6
Other expense, net -$58.1 -$77.0 -$163.1 -$189.4
Income (loss) before income taxes $93.6 -$46.1 $109.6 $207.2
Income tax provision $30.9 $7.5 $23.8 $53.1
Net income (loss) $62.7 -$53.6 $85.8 $154.1
Dividends on Series A Preferred Stock -$27.8 $— -$83.4 $—
Net income (loss) attributable to common stockholders $34.9 -$53.6 $2.4 $154.1
Basic net income (loss) per common share $0.06 -$0.10 $— $0.29
Diluted net income (loss) per common share $0.06 -$0.10 $— $0.28
Basic common shares outstanding 540.8 537.4 540.0 536.9
Diluted common shares outstanding 545.5 537.4 544.3 542.1

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions; unaudited)

December 31, 2025 March 31, 2025
ASSETS
Cash and short-term investments $250.7 $771.7
Accounts receivable, net $731.2 $689.7
Inventories $1,057.7 $1,293.5
Other current assets $251.0 $236.4
Total current assets $2,290.6 $2,991.3
Property, plant and equipment, net $1,130.0 $1,183.7
Other assets $10,904.9 $11,199.6
Total assets $14,325.5 $15,374.6
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable and accrued liabilities $1,059.3 $1,155.1
Total current liabilities $1,059.3 $1,155.1
Long-term debt $5,366.0 $5,630.4
Long-term income tax payable $572.7 $633.4
Long-term deferred tax liability $29.6 $33.8
Other long-term liabilities $737.5 $843.6
Stockholders’ equity $6,560.4 $7,078.3
Total liabilities and stockholders’ equity $14,325.5 $15,374.6